FutureCure Health expands vertigo diagnosis and treatment services through NeuroEquilibrium network

FutureCure Health is expanding access to diagnosis and treatment for vertigo and balance disorders in India through its wholly owned subsidiary NeuroEquilibrium.

According to the company, nearly six crore people in India suffer from vertigo and balance disorders. Many cases are misdiagnosed or managed only with symptom-suppressing medication instead of addressing the root cause of the condition. FutureCure Health stated that it is working to address this gap by expanding evidence-based care through NeuroEquilibrium, which focuses on diagnosis and treatment of vertigo and balance disorders.

While many treatment approaches focus on symptom management, NeuroEquilibrium identifies the cause of vertigo in the inner ear, brain, or balance system so that treatment can be directed to the underlying condition. The company works with hospitals, ENT clinics, and neurology centres to support diagnosis and treatment. According to the company, NeuroEquilibrium has diagnosed and treated more than 150,000 patients.

Anita Bhandari, Founder of FutureCure Health, said: “Vertigo/dizziness is often misdiagnosed, leaving patients untreated for years. Our work with more than 150,000 patients proves that accurate diagnosis changes outcomes.”

NeuroEquilibrium currently operates nine clinics in Gurugram, located in Sector 28 (DLF Phase 1), Sector 56, Sushant Lok 2, South City 1, Sector 51, Sector 38, New Railway Road, Sector 90, and Palam Vihar.

FutureCure Health also reported that it recently raised Rs 104 crore in a completed funding round led by Carnelian Asset Management LLP and other investors. The company stated that the fundraising follows a USD 4 million funding round in 2022 supported by Kotak Alternate Asset Management, RVCF Ventures and Unicorn India Ventures.

Rajneesh Bhandari, Founder of FutureCure Health, said; “This funding has reinforced our conviction that globally relevant healthcare technologies can be built in India. As we scale NeuroEquilibrium across hospitals in India and international markets and expand into chronic lifestyle diseases such as migraine and diabetes, our focus is on using technology to bridge the shortage of specialist doctors. Precise, scalable diagnostics can democratise super-speciality healthcare and act as a true force multiplier for better outcomes.”